Tag: Drugs (Pharmaceuticals)

New Research Finds Potential Alternative to Abortion Pill Mifepristone

A new study suggests a possible alternative to the abortion pill mifepristone, a drug that continues to be a target of lawsuits and legislation from abortion opponents. But the potential substitute could further complicate the politics of reproductive health because it is also the key ingredient in a contraceptive morning-after pill. The new study, published […]

Read More

Man Charged With Giving Fake Botox Injections That Sickened Clients

Joey Grant Luther promised the clients of his Manhattan medical spa faces that were less wrinkled, eyes that were more youthful, and genitalia that were larger, all through the magic of injectable treatments like Botox. Instead, prosecutors said, many of those clients were left with botulism, impaired vision and other maladies after Mr. Luther illegally […]

Read More

If You’re Retired, or Not: 5 Changes That Will Affect Your Money in 2025

Amid the global turmoil of this young new year comes a flurry of welcome developments that will help many people — especially retirees and those close to retirement — supercharge their savings, cut prescription drug costs, keep more of the money they earn and, possibly, raise their credit scores. Fair warning, though: It’s complicated. The […]

Read More

RFK Jr. Sought to Stop Covid Vaccinations 6 Months After Rollout

Robert F. Kennedy Jr., President-elect Donald J. Trump’s choice to lead the nation’s health agencies, formally asked the Food and Drug Administration to revoke the authorization of all Covid vaccines during a deadly phase of the pandemic when thousands of Americans were still dying every week. Mr. Kennedy filed a petition with the F.D.A. in […]

Read More

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be negotiated directly between the government and drug makers. The Biden administration announced the list on Friday, but the incoming Trump administration will oversee the price […]

Read More

Insulin Prices Dropped. But Some Poor Patients Are Paying More.

Maricruz Salgado was bringing her diabetes under control. Thanks to a federal program that allowed health clinics that serve poor people to buy drugs at steeply discounted prices, she was able to pay less than $75 for all five of her diabetes medications every three months. But in July, the cost of three of those […]

Read More

FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats

The Food and Drug Administration on Wednesday banned the use of Red Dye No. 3 in food, beverages and drugs, more than three decades after the synthetic coloring was first found to cause cancer in male laboratory rats. The dye, a petroleum-based additive, has been used to give candy, soda and other products their vibrant […]

Read More

How a Company Makes Millions Off a Hospital Program Meant to Help the Poor

Soon after being diagnosed with metastatic breast cancer, Virginia King sat in an outpatient clinic in Santa Fe, N.M, while a nurse injected her with a powerful drug to slow damage to her spine, where the disease had spread. Even though the drug had a list price of about $2,700, the hospital that owned the […]

Read More

Drug Company to Share Revenues With Indigenous People Who Donated Their Genes

When Stephane Castel first met with a group of Māori people and other Pacific Islanders in New Zealand to talk about his drug company’s plans for genetic research, locals worried he might be seeking to profit from the genes of community members without much thought to them. Instead, Dr. Castel and his colleagues explained, they […]

Read More

In France, Drug Traffic Spreads to Small Towns

For centuries in Morlaix, a city of cobblestones and creperies on the Breton coast of France, the best-known dealers were the ones who traded in linen during the Renaissance and built a number of unique half-timbered houses in the middle of town. The new dealers are another story. France, long a major European market for […]

Read More